RISPERDAL

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Spain, Finland, France, Hong Kong, Ireland, Israel, Italy, Japan, Malta, Mexico, Netherlands, New Zealand, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug RISPERDAL contains one active pharmaceutical ingredient (API):

1 Risperidone UNII L6UH7ZF8HC - RISPERIDONE

Risperidone is a selective monoaminergic antagonist with unique properties. Although risperidone is a potent D2 antagonist, which is considered to improve the positive symptoms of schizophrenia, it causes less depression of motor activity and induction of catalepsy than classical antipsychotics. Read about Risperidone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RISPERDAL Tablet / Tablet orally disintegrating / Solution	FDA, National Drug Code (US)	MPI, US: SPL/PLR
RISPERDAL CONSTA Powder and solvent for suspension for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AX08	Risperidone	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11872W, 11873X, 11874Y, 11877D, 11879F, 11882J, 1842Y, 1846E, 3169T, 3170W, 3171X, 3172Y, 8100H, 8780D, 8781E, 8782F, 8789N, 9079W, 9293D
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 514504201117311, 514504203136313, 514504204116316, 514504205112314, 514505701113313, 514505801118317, 514507104155314, 514507105151312, 514507106158310, 514518050034503, 514518050034603, 514518050034703
Country: CA	Health Products and Food Branch	Identifier(s): 02236950, 02255707, 02255723, 02255758, 02298465
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00596085, 01816086, 01816146, 01816152, 01816181, 07700640
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 22.431-1-03-05, 24.467-1-03-12, 24.468-05-02, 24.469-1-03-12, 26.160-02-05, 26.161-02-05, 26.162-02-05, 26.887-02-06
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60335, 60336, 62096, 62803, 65213, 65214, 65215
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 000005, 070020, 070031, 070042, 070797, 567263, 567503, 567511, 567529, 567537
Country: FR	Base de données publique des médicaments	Identifier(s): 60260497, 63605525, 65893318, 68878549, 68901873, 69505147, 69556750
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 146611, 162347, 162349, 162351, 162353, 162355, 198598, 368736, 368738, 368740, 398347, 41668, 41671, 45208
Country: HK	Department of Health Drug Office	Identifier(s): 42267, 50820, 50821, 50822, 50823, 51039, 51040, 51064
Country: IE	Health Products Regulatory Authority	Identifier(s): 29204, 44013, 44020, 44062, 44089, 44090, 44094, 44132, 44226, 45224, 45232, 45492, 45493, 45494
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3050, 3051, 3052, 3113, 4122, 4612, 4613, 4614
Country: IT	Agenzia del Farmaco	Identifier(s): 028752057, 028752069, 028752071, 028752083, 028752095
Country: JP	医薬品医療機器総合機構	Identifier(s): 1179038C1027, 1179038F1023, 1179038F2020, 1179038F3026, 1179038F5029, 1179038F6025, 1179038F7021, 1179407G1026, 1179407G2022, 1179407G3029
Country: MT	Medicines Authority	Identifier(s): MA018/00201, MA018/00202, MA018/00203, MA018/00204, MA018/00205, MA018/00206, MA018/00207
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 039M95, 098M93, 270M2002, 589M2002
Country: NL	Z-Index G-Standaard	Identifier(s): 14001098
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 116939, 116947, 116955, 37710, 37729, 37737, 37745, 44016, 56197
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10531, 10532, 10533, 6753, 6754, 6756, 6757, 6758, 8535
Country: SG	Health Sciences Authority	Identifier(s): 08058P, 08061P, 09905P, 12354P, 12355P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699593091148, 8699593091155, 8699593091162, 8699593091179, 8699593595059, 8699593781018, 8699593781025, 8699593781032
Country: US	FDA, National Drug Code	Identifier(s): 50458-300, 50458-301, 50458-302, 50458-305, 50458-315, 50458-320, 50458-325, 50458-330, 50458-335, 50458-350, 50458-355, 50458-395, 55289-463, 55289-465, 55289-491, 55289-519, 70518-1763, 70518-2160, 70518-2161
Country: ZA	Health Products Regulatory Authority	Identifier(s): 30/2.6.5/0215, 37/2.6.5/0142, 37/2.6.5/0144, 37/2.6.5/0320, 37/2.6.5/0321, A40/2.6.5/0204, A40/2.6.5/0205